CD69 and neoplasm: ZFP36 KO did not alter antigen-induced CD25 and CD69 expression in CD4 or CD8 mesoCAR-T cells, nor did it change the percentage of CD25+ CD69+ cells without tumor cells (Fig. 4A, B).